The effect of taurine on cholesterol metabolism

Molecular Nutrition and Food Research

Volumn 56, Issue 5, 2012, Pages 681-690

  Chen, Wen ^a   Guo, Jun Xia ^a   Chang, Ping ^a  

^a BEIJING UNION UNIVERSITY   (China)

Author keywords

Bile acid; Cholesterol; Cholesterol 7a hydroxylase; Low density lipoprotein receptor; Taurine

Indexed keywords

BILE ACID; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TAURINE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECT; HYPERCHOLESTEROLEMIA; LIVER; METABOLISM; REVIEW;

ANIMALS; BILE ACIDS AND SALTS; CHOLESTEROL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; DISEASE MODELS, ANIMAL; HYPERCHOLESTEROLEMIA; LIVER; TAURINE;

ANIMALIA;

EID: 84861689126     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100799     Document Type: Review

References (69)

1. Huxtable, R. J., Physiological actions of taurine. Physiol. Rev. 1992, 72, 101-163.
2. Raiha, N., Rassin, D., Heinonen, K., Gaull, G. E., Milk protein quality and quantity: biochemical and growth effects in low birth weight infants (LBWI). Pediatr. Res. 1975, 9, 370.
3. Geggel, H. S., Ament, M. E., Heckenlively, J. R., Nutritional requirement for taurine in patients receiving long-term parenteral nutrition. N. Engl. J. Med. 1985, 312, 142-146.
4. Sheik, K., Toskes, P., Dawson, W., Taurine deficiency and retinal defects associated with small intestinal bacterial overgrowth. Gastroenterology 1981, 80, 1363.
5. Sturman, J. A., Taurine in development. Physiol. Rev. 1993, 73, 119-147.
6. Kuriyama, K., Taurine as a neuromodulator. Fed. Proc. 1980, 39, 2680-2684.
7. Wright, C. E., Tallan, H. H., Lin, Y. Y., Taurine: biological update. Annu. Rev. Biochem. 1986, 55, 427-453.
8. Thurston, J. H., Hauhart, R. E., Dirgo, J. A., Taurine: a role in osmotic regulation of mammalian brain and possible clinical significances. Life Sci. 1980, 26, 1561-1568.
9. Pasantes, M. H., Wright, C. E., Gaull, G. E., Taurine protection of lymphoblastoid cells from iron-ascorbate-induced damage. Biochem. Pharmacol. 1985, 34, 2205-2207.
10. Danielsson, H., Present states of research on catabolism and excretion of cholesterol. Adv. Lipid Res. 1963, 1, 335-385.
11. Tsuji, K., Seki, T., Iwao, H., Cholesterol-lowering effects of taurine and sulfur-containing amino acids in serum and liver of rats. Sulfur-Containing Amino Acids 1979, 2, 143-145.
12. Sugiyama, K., Ohishi, A., Ohnuma, Y., Muramatsu, K., Comparison between the plasma cholesterol-lowering effects of glycine and taurine in fats fed on high cholesterol diets. Agric. Biol. Chem. 1989, 53, 1647-1652.
13. Venkatesan, N., Rao, P. V., Arumugam, V., Inhibitory effect of taurine on puromycin aminonucleoside-induced hyperlipidemia in rats. J. Clin. Biochem. Nutr. 1993, 15, 203-210.
14. Yokogoshi, H., Mochizuki, H., Nanami, K., Hida, Y. et al., Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J. Nutr. 1999, 129, 1705-1712.
15. Mochizuki, H., Takido, J., Yokogoshi, H., Improved suppression by dietary taurine of the fecal excretion of bile acids from hypothyroid rats. Biosci. Biotechnol. Biochem. 1999, 63, 753-755.
16. Mochizuki, H., Takido, J., Yokogoshi, H., Effect of dietary taurine on endogenous hypercholesterolemia in rats fed on phenobarbital-containing diets. Biosci. Biotechnol. Biochem. 1999, 63, 1298-1300.
17. Mochizuki, H., Oda, H., Yokogoshi, H., Dietary taurine potentiates polychlorinated biphenyl-induced hypercholesterolemia in rats. J. Nutr. Biochem. 2001, 12, 109-115.
18. Nishimura, N., Umeda, C., Oda, H., Yokogoshi, H., The effect of taurine on plasma cholesterol concentration in genetic type 2 diabetic GK rats. J. Nutr. Sci. Vitaminol. 2002, 48, 483-490.
19. Chen, W., Suruga, K., Nishimura, N., Gouda, T. et al., Comparative regulation of major enzymes in bile acids biosynthesis pathways by cholesterol, cholic acid and taurine in mice and rats. Life Sci. 2005, 77, 746-757.
20. Kibe, A., Wake, C., Kuramoto, T., Hoshita, T., Effect of dietary taurine on bile acid metabolism in guinea pigs. Lipids 1980, 15, 224-229.
21. Chang, Y. Y., Chou, C. H., Chiu, C. H., Yang, K. T. et al., Preventive effects of taurine on development of hepatic steatosis induced by a high-fat/cholesterol dietary habit. J. Agric. Food. Chem. 2011, 59, 450-457.
22. Jones, M. P., Pandak, W. M., Hylemon, P. B., Chiang, J. Y. L. et al., Cholesterol 7α-hydroxylase: evidence for transcriptional regulation by cholesterol and /or metabolic products of cholesterol in the rat. J. Lipid Res. 1993, 34, 885-892.
23. Doerner, K. C., Gurley, E. C., Vlahcevic, Z. R., Hylemon, P. B., Regulation of cholesterol 7α-hydroxylase expression by sterols in primary hepatocyte cultures. J. Lipid Res. 1995, 36, 168-177.
24. Zulli, A., Lau, E., Wijaya, B. P. P., Jin, X. et al., High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery: association with reduced CCAAT/enhancer binding protein homologous protein and total plasma homocysteine but not lipidemia. Hypertension 2009, 53, 1017-1022.
25. Balkan, J., Oztezcan, S., Hatipoglu, A., Cevikbas, U. et al., Effect of a taurine treatment on the regression of existing atherosclerotic lesions in rabbits fed on a high-cholesterol diet. Biosci. Biotechnol. Biochem. 2004, 68, 1035-1039.
26. Scarabottolo, L., Trezzi, E., Roma, P., Catapano, A. L., Experimental hypothyroidism modulates the expression of the low density lipoprotein receptor by the liver. Atherosclerosis 1986, 59, 329-333.
27. Oda, H., Yoshida, A., Effect of feeding xenobiotics on serum high density lipoprotein and apolipoprotein A-I. Biosci. Biotechnol. Biochem. 1994, 58, 1646-1651.
28. Nagaoka, S., Masaki, H., Aoyama, Y., Yoshida, A., Effects of excess dietary tyrosine or certain xenobiotics on cholesterogenesis in rats. J. Nutr. 1986, 116, 726-732.
29. Campos, H., Granest, J. J. Jr., Bilijievents, E., McNamara, J. R. et al., Low density lipoprotein particle size and coronary artery disease. Arterioscler. Thromb. 1992, 12, 187-195.
30. Coresh, J., Kwiteroviwich, P. O. Jr., Smith, H. H., Bachorik, P. S., Association of plasma triglyceride concentration and LDL particle diameter, density and chemical composition with premature coronary artery disease in men and women. J. Lipid Res. 1993, 34, 1887-1897.
31. Brown, M. S., Goldstein, J. L., A receptor mediated pathway for cholesterol homeostasis. Science 1986, 232, 34-47.
32. Murakami, S., Kondo, Y., Toda, Y., Kitajima, H. et al., Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine. Life Sci. 2002, 70, 2355-2366.
33. Huxtable, R.J., Laird, H. E., Lippincott, S. E., The transport of taurine in the heart and rapid depletion of tissue taurine content by guanidinoethyl sulfonate. J Pharmacol. Exp. Ther. 1979, 211, 465-471.
34. Chen, W., Matuda, K., Nishimura, N., Yokogoshi, H., The effect of taurine on cholesterol degradation in mice fed a high-cholesterol diet. Life Sci. 2004, 74, 1889-1898.
35. Li, X., Catalina, F., Grundy, S. M., Patel, S., Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid turnover of VLDL and preferential removal of B-48-relative to B-100-containing lipoproteins. J. Lipid Res. 1996, 37, 210-220.
36. Olofsson, SO., Boren, J., Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis. J. Intern Med. 2005, 258, 395-410.
37. Yanagita, T., Han, S. Y., Hu, Y., Nagao, K. et al., Taurine reduces the secretion of apolipoprotein B100 and lipids in HepG2 cells. Lipids Health Dis. 2008, 7, 38-43.
38. Sjovall, J., Fifty years with bile acids and steroids in health and disease. Lipids 2004, 39, 703-722.
39. Chiang, J. Y. L., Regulation of bile acid synthesis. Front. Biosci. 1998, 3, 176-193.
40. Vlahcevic, Z. R., Pandak, W. M., Stravit, R. T., Regulation of bile acid biosynthesis. Gastroenterol. Clin. North Am. 1999, 28, 1-25.
41. Boone, L. R., Brooks, P. A., Niesen, M. I., Ness, G. C., Mechanism of resistance to dietary cholesterol. J. Lipids 2011, 10, 1242-1251.
42. Cheema, S. K., Cikaluk, D., Agellon, L. B., Dietary fats modulate the regulatory potential of dietary cholesterol on cholesterol 7α-hydroxylase gene expression. J. Lipid Res. 1997, 38, 315-323.
43. Dueland, S., Drisko, J., Graf, L., Machleder, D. et al., Effect of dietary cholesterol and taurocholate on cholesterol 7α- hydroxylase and hepatic LDL receptors in inbred mice. J Lipid Res. 1993, 34, 923-931.
44. Biddinger, S. B., Almind, K., Miyazaki, M., Kokkotou, E. et al., Effects of diet and genetic background on sterol regulatory element-binding protein-1c, linebreak stearoyl-CoA desaturase 1, and the development of the metabolic syndrome. Diabetes 2005, 54, 1314-1323.
45. Ness, G. C., Gertz, K. R., Hepatic HMG-CoA reductase expression and resistance to dietary cholesterol. Exp. Biol. Med. 2004, 229, 412-416.
46. Lam, N. V., Chen, W., Suruga, K., Nishimura, N. et al., Enhancing effect of taurine on CYP7A1 mRNA expression in HepG2 cells. Amino Acids 2006, 30, 43-48.
47. Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., Mangelsdorf, D. J., An oxysterol signalling pathway mediated by nuclear receptor LXR alpha. Nature 1996, 383, 728-731.
48. Wang, H., Chen, J., Hollister, K., Sowers, L. C., Forman, B. M., Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell 1999, 3, 543-553.
49. Stroup, D., Crestani, M., Chiang, J. Y. L., Identification of a bile acid response element in the cholesterol 7 alpha-hydroxylase gene CYP7A. Am. J. Physiol. 1997, 273, G508-517.
50. Chiang, J. Y. L., Kimmel, R., Stroup, D., Regulation of cholesterol 7α-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRα). Gene 2001, 262, 257-265.
51. Peet, D. J., Truly, S. D., Ma, W., Janowski, B. A. et al., Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR-α. Cell 1998, 93, 693-704.
52. Agellon, L. B., Drover, V. A., Cheema, S. K., Gbaguidi, G. F., Walsh, A., Dietary cholesterol fails to stimulate the human cholesterol 7alpha-hydroxylase gene (CYP7A1) in transgenic mice. J. Biol. Chem. 2002, 277, 20131-20134.
53. Lehmann, J. M., Kliewer, S. A., Moore, L. B., Smith-Oliver, T. A. et al., Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 1997, 272, 3137-3140.
54. Crestani, M., Sadeghpour, A., Stroup, D., Gali, G., Chiang, J. Y.L., Transcriptional activation of the cholesterol 7α-hydroxylase gene (CYP7A1) by nuclear hormone receptors. J. Lipid Res. 1998, 39, 2192-2200.
55. Nitta, M., Ku, S., Brown, C., Okamoto, A. Y., Shan, B., CPF: an orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7α-hydroxylase gene. Proc. Natl. Acad. Sci. USA 1999, 96, 6660-6665.
56. Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M. et al., Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000, 102, 731-744.
57. Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A. et al., A regulatory cascade of the nuclear receptors FXR, SHP-1 and LRH-1 represses bile acid biosynthesis. Mol. Cell 2000, 6, 517-526.
58. Li-Hawkins, J., Gåfvels, M., Olin, M., Lund, E. et al., Cholic acid mediates negative feedback regulation of bile acid synthesis in mice. J. Clin. Invest. 2002, 110, 1191-1200.
59. Lam, N. V., Chen, W., Suruga, K., Nishimura, N. et al., Effects of taurine on mRNA levels of nuclear receptors and factors involved in cholesterol and bile acid homeostasis in mice. Adv. Exp. Med. Biol. 2006, 583, 193-202.
60. Yu, L., Li-Hawkins, J., Hammer, R. E., Berge, K. E. et al., Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J. Clin. Invest. 2002, 110, 671-680.
61. Yu, L., Hammer, R. E., Li-Hawkins, J., Von Bergmann, K. et al., Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 16237-16242.
62. Yu, L., Gupta, S., Xu, F., Liverman, A. D. B. et al., Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J. Biol. Chem. 2005, 280, 8742-8747.
63. Chiang, J. Y. L., Bile acid: regulation of synthesis. J. Lipid Res. 2009, 50, 1955-1966.
64. Ananthanarayanan, M., Balasubramanian, N., Makishima, M., Mangelsdorf, D. J., Suchy, F. J., Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J. Biol. Chem. 2001, 276, 28857-28865.
65. Li, H., Chen, F., Shang, Q., Pan, L. et al., FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288, G60-66.
66. Tu, H., Okamoto, A. Y., Shan, B., FXR: a bile acid receptor and biological sensor. Trends Cardiovasc. Med. 2000, 10, 30-35.
67. Kim, I., Ahn, S. H., Inagaki, T., Choi, M. et al., Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J. Lipid Res. 2007, 48, 2664-2672.
68. Chen, W., Nishimura, N., Oda, H., Yokogoshi, H. et al., The effect of taurine on cholesterol degradation and bile acids pool. Adv. Exp. Med. Biol. 2003, 526, 261-268.
69. Mochizuki, H., Takido, J., Oda, H., Yokogoshi, H., Improving effect of dietary taurine on marked hypercholesterolemia induced by a high cholesterol diet in streptozotocin induced diabetic rats. Biosci. Biotechnol. Biochem. 1999, 63, 1984-1987.